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Abstract 
Background 
Mycobacterium tuberculosis is characterised by limited genomic diversity, which makes the 
application of whole genome sequencing particularly attractive for clinical and 
epidemiological investigation. However, in order to confidently infer transmission events, an 
accurate knowledge of the rate of change in the genome over relevant timescales is required. 
Methods 
We attempted to estimate a molecular clock by sequencing 199 isolates from 
epidemiologically linked tuberculosis cases, collected in the Netherlands spanning almost 16 
years. 
Results 
Multiple analyses support an average mutation rate of ~0.3 SNPs per genome per year. 
However, all analyses revealed a very high degree of variation around this mean, making the 
confirmation of links proposed by epidemiology, and inference of novel links, difficult. 
Despite this, in some cases, the phylogenetic context of other strains provided evidence 
supporting the confident exclusion of previously inferred epidemiological links. 
Conclusions 
This in-depth analysis of the molecular clock revealed that it is slow and variable over short 
time scales, which limits its usefulness in transmission studies. However, the superior 
resolution of whole genome sequencing can provide the phylogenetic context to allow the 
confident exclusion of possible transmission events previously inferred via traditional DNA 
fingerprinting techniques and epidemiological cluster investigation. Despite the slow 
generation of variation even at the whole genome level we conclude that the investigation of 
tuberculosis transmission will benefit greatly from routine whole genome sequencing. 
Keywords 
Mycobacterium tuberculosis, Molecular clock, Whole genome sequencing, Transmission, 
Epidemiology 
Background 
The global burden of tuberculosis remains enormous, resulting in 1.4 million deaths, and 8.7 
million new cases in 2011 [1]. Understanding transmission dynamics, and the host and 
pathogen factors that can affect the spread of tuberculosis, is vital for understanding 
epidemiology and for effective outbreak management. In order to achieve this, the accurate 
identification of transmission events through epidemiological and molecular techniques is 
essential. 
In the last two decades several DNA fingerprinting methods for Mycobacterium tuberculosis 
were developed that reveal different types of DNA polymorphisms in the genome [2]. The 
first typing method developed used IS6110 restriction fragment length polymorphism (RFLP) 
analysis, but variable number of tandem repeat (VNTR) typing is currently recognised as the 
gold standard [3,4]. In the Netherlands, a country with a low incidence of tuberculosis (6.5 
per 100,000 people), epidemiological links between patients are considered “confirmed” if 
two conditions are met: 1) two M. tuberculosis isolates have an identical RFLP or VNTR 
profile and 2) interviews suggest that both patients could have been in contact with each 
other. Genomic changes that are independent of sites monitored by RFLP/VNTR typing, 
however, are unaccounted for. For some questions concerning the disease, the application of 
RFLP and VNTR typing is limited. For example Niemann et al. found that two M. 
tuberculosis isolates had the same RFLP type but differed by 130 SNPs when whole genome 
sequencing was used [5]. Likewise, isolates with identical DNA fingerprints may not always 
be epidemiologically linked. For example Gardy et al. found that VNTR typing data 
suggested a tuberculosis outbreak in Canada was clonal, whereas whole genome sequencing 
data revealed that there were in fact two concurrent outbreaks [6]. Moreover, RFLP and 
VNTR typing may suffer from a slow genetic turn over that reduces their usefulness when 
epidemiological clusters grow over extended time periods. In such case the distinction 
between spread from primary, secondary, tertiary, etc., sources in the cluster becomes 
impossible, Whole genome sequencing allows investigation into genomic evolution and 
transmission at the highest resolution. This level of information can help refine conclusions 
drawn from traditional fingerprinting methods. The application of sequencing to a large 
outbreak in Harlingen, the Netherlands, provided a higher resolution picture than could be 
inferred from typing alone, and reduced the possible number of infection routes for all 
patients, which agreed with epidemiological investigations [7]. 
Due to its slow growth and limited genomic diversity, routine application of clinical whole 
genome sequencing is particularly attractive for M. tuberculosis. This will make the 
determination of both antibiotic resistance and transmission events more rapid [8]. However, 
in order to confidently conclude transmission, knowledge of the mutation rate is required. 
Whole genome sequencing has demonstrated that M. tuberculosis is characterized by low 
genomic diversity [9] suggesting that its mutation rate is low. However, very few studies 
have attempted to make an accurate measurement of mutation rate. Ford et al. showed using 
whole genome sequencing, that the mutation rate of M. tuberculosis during active infection of 
macaques is approximately 0.39 (0.16-0.80 95% CI) single nucleotide polymorphisms per 
genome per year [10]. However, this was based on only 15 isolates collected from four 
infections. More recently, an estimate of 0.5 SNPs/genome/year has been made on the basis 
of within and between patient sampling of 93 patients from a larger study in the UK [11]. In 
order to better understand the mutation rate in M. tuberculosis during transmission, the 
genomes of 199 isolates were sequenced. These included isolates from 185 patients with 
known epidemiological links, and another 14 patient isolates from the same RFLP clusters 
but with no evident epidemiological link. Here we assess the usefulness of the molecular 
clock and the phylogenetic resolution provided by whole genome sequencing to both refute 
and affirm epidemiological inference. 
Methods 
Contact tracing 
Contact tracing was carried out as part of routine handling by the Municipal Health Service in 
Amsterdam, and performed following the stone-in-the-pond principle [12]. Contacts were 
examined in groups, located in concentric circles around the source case, until the observed 
prevalence of tuberculosis infection corresponds with the expected prevalence. Patients 
whose isolates had an identical IS6110 RFLP fingerprint were extensively interviewed. The 
data of these interviews were combined with the contact tracing results, and anonymised for 
this analysis; therefore data protection permission and ethical approval were not required. 
Genotyping methods 
IS6110 restriction fragment length polymorphism (RFLP) typing was performed for all 
isolates in the study. Spoligotyping, 24-locus variable number of tandem repeats (VNTR) 
typing were performed on some isolates by the standardized methods detailed elsewhere 
[3,13,14]. 
Strain selection 
Strains of 42 IS6110 RFLP clusters that contained isolates of epidemiologically linked TB 
patients were selected for whole genome sequencing. Patient data was anonymised and un-
identifiable, therefore ethical approval and informed consent were not required. As control 
strains, the source case isolate and the isolate of the fifth patient in a transmission chain of the 
Harlingen cluster that were part of an earlier WGS study [9] were sequenced. Using 454-
sequencing and comparative analysis, these two genome sequences had been determined to 
differ by four SNPs [9]. Also, four multidrug resistant (MDR) isolates of patients diagnosed 
in Estonia, of which two were linked by transmission, were sequenced. These isolates are 
representative of cluster EU0051 [15] (de Beer et al., manuscript in preparation) that is one of 
the largest European MDR –clusters to date. DNA was isolated according to the previously 
published protocol [16]. 
Library construction and sequencing 
Libraries were constructed in 18 pools of isolates with each isolate uniquely tagged. Each 
pool was subjected to paired-end sequencing on a single lane of the Illumina Genome 
Analyzer GAIIx platform. Thirty-three of the isolates were sequenced with a read length of 
76 bases and the remaining 166 with a read length of 108 bases. All raw sequence data used 
in this work have been deposited in the European Nucleotide Archive under Study Accession 
Number: ERP000111. 
Data analysis 
Reads were mapped to a corrected version of the H37Rv reference [17] using the program 
SMALT [18]; and a combination of samtools and bcftools [19] were used to call bases as part 
of an in-house pipeline. Appropriate filters were used to reduce the number of false positive 
SNP calls to a level estimated to be less than 1 SNP per genome. These included at least 75% 
of high quality mapped reads on each strand agreeing with the call, a base quality score of at 
least 50 and a mapping quality score of at least 30. Reads which did not map uniquely were 
discarded, which means repetitive regions are avoided. Mapping and SNP calling were also 
carried out independently at the Center of Molecular and Biomolecular Informatics (CMBI), 
Radboud University, using RoVar (Robust Variant detection in genome sequences using Next 
Generation Data from various platforms). RoVar is available upon request from the authors 
(https://trac.nbic.nl/rovar/, V.C.L. de Jager, B.A.M. Renckens, R.J. Siezen, and S.A.F.T. van 
Hijum, unpublished). The mapping results were compared using the epidemiological linked 
pairs as a test set. Most SNPs were found to agree except those found in regions flanking 
insertions. This problem was avoided by only calling deletions in the final mapping. As short 
insertions and deletions are difficult to call in general, only SNPs were considered for all 
subsequent analysis. The repetitive and GC rich PE/PPE gene family are known to be 
problematic for analysis with short read data. Most variants in these regions were filtered out 
due to the quality controls mentioned above. However, to completely account for the 
possibility of unreliable SNPs called in these regions, the mutation rate analyses were 
repeated with these regions removed (Additional file 1). It should be noted that this made no 
impact on the conclusions drawn. 
Phylogenetic analysis 
A maximum likelihood tree was constructed based on variable positions using RAxML [20]. 
Homoplasic SNPs (indicated by identical SNPs that occurred on independent branches of the 
tree) were inspected manually to discount any that were likely to be the result of incorrect 
mapping. Path-O-Gen was used to plot root to tip distance against time [21]. This program 
uses linear regression to root trees with date information at the position that is most 
compatible with the assumption of the presence of a molecular clock. 
Results 
Whole genome phylogeny and microevolution between epidemiologically 
linked pairs 
For this study, 199 isolates were selected at the Municiple Health Service in Amsterdam 
representing 42 RFLP clusters of various sizes (Additional file 2). This included 97 pairs of 
isolates for which an epidemiological link was established via contact tracing within the 
RFLP clusters. The selection included strains of a variety of spoligotype-defined lineages and 
drug resistance profiles. DNA from each of these isolates was sequenced using the Illumina 
platform, generating an average coverage of 95.6% of the genome to a depth of 
approximately 100 fold. Mapping of this data from the 199 isolates to the H37Rv reference 
genome revealed 11,879 positions that had a SNP in at least one of the isolates. A maximum-
likelihood phylogeny was constructed based on positions of the genome found to contain a 
SNP, revealing four of the globally dominant lineages (Figure 1). All RFLP defined clusters 
were in agreement with clusters identified on the whole genome SNP tree. 
Figure 1 Maximum likelihood phylogeny of 199 M.tuberculosis strains from 11,879 
single nucleotide polymorphisms. Lineages are indicated as described by [22]. 
The genetic distance was calculated between each of the 97 pairs by comparing the SNPs 
called in each isolate. A SNP difference was only counted where there was high confidence 
in the base call in both isolates. The linked pairs had a mean SNP difference of 3.42 (range of 
0–149) and 37 of the pairs had no detectable SNP difference (Figure 2) demonstrating high 
genomic stability. 
Figure 2 Pairwise genetic distances between M. tuberculosis isolates from patients linked 
by contact tracing. The genetic distances consist of the number of identified single 
nucleotide polymorphisms that differed between the genomes of two linked isolates. 
Convergent evolution of drug resistance 
Eight of the epidemiologically linked pairs had different drug susceptibility phenotypes for 
streptomycin and isoniazid. In five of the pairs, a resistant phenotype was found in the 
primary case isolate, and in three of the pairs it was found in the secondary (see Additional 
file 3). However no SNPs in genes known or suspected to confer drug resistance were 
identified to differ between the pairs. In addition minority variants and InDels (insertions and 
deletions) were also investigated, but no additional variants could be detected. Although this 
could indicate an undetected mechanism or variant which determines resistance, it may also 
be due to inaccuracies in the phenotypic resistance tests. 
In total, 16 non-synonymous SNPs were found to be homoplasic (Additional file 4). Five of 
these found in genes rpoB [23], gyrA [24], rrs [25], katG [26] and embB [27] have previously 
been associated with drug resistance. Two of the other homoplasic SNPs occurred in genes 
thought to be involved in pathogenicity: ino1 [28] and opcA [29]. One possibility is that 
convergent evolution could be a result of recombination. It has recently been suggested that 
recombination is frequent and widespread within the M. tuberculosis species [30], which is 
counter to a widespread belief that it is strictly clonal. We analysed our data using a 
recombination detection program [31] and found no evidence of recombination in our dataset. 
Instead, it is more likely that homoplasy has occurred in these genes due to a high selective 
pressure for traits such as antibiotic resistance. This suggests that the other 11 homoplasic 
SNPs with no ascribed function deserve further investigation, as they may possibly represent 
previously un-described pathogenicity or antibiotic-resistance genes conferring selective 
advantages or potential compensatory mutations [32]. 
Deriving a molecular clock 
In order to make a judgment about whether direct transmission has taken place using whole 
genome sequencing data, knowledge of the mutation rate is required. Here we have attempted 
to estimate this using the epidemiologically linked pairs. Estimates were calculated using 
SNPs accumulated in the secondary case in each of the linked pairs. SNPs found only in the 
primary case isolate were excluded as these are likely to represent either variation in the 
source host population that is not present in the transmitted population, or SNPs generated via 
laboratory passage. SNPs conferring drug resistance were excluded (n = 7), as these are likely 
to be subject to strong selection. In addition three pairs were excluded based on the 
phylogenetic evidence discussed below. The mutation rate was estimated per pair, with 
sources of error such as diagnostic delay and false positive and false negative SNP calls taken 
into account (See Additional file 5). The average estimates were wide ranging (0.4-17) with a 
mean of 5.37 SNPs per genome per year (see Additional file 5). No association between 
higher estimates and patient factors including sex, country of birth, treatment and drug 
susceptibility of the isolates was found (Fishers exact test P values 0.11 - 1). 
When the number of SNPs accumulated was plotted against time elapsed for each patient pair 
a poor correlation was observed (Figure 3a). However, when drug resistant and sensitive 
pairs were plotted separately an improved correlation for sensitive pairs was observed, 
probably due to a lack of correlation for drug resistant pairs (Figure 3b, c). We speculate that 
this may be due to the different selection pressures and effective population sizes of the two 
groups. The slope of the graph provides an estimate of mutation rate, and for the sensitive 
isolates this is 0.32 SNPs per genome per year but with a large degree of variation around the 
mean reflected by an r2 value of 0.17. This variability could reflect a number of sources of 
error that have to be taken into account. The first possible source of error is the reliance on 
the assumption that the epidemiological inference is correct and that there was true direct 
transmission between the patient pairs. Secondly, there is an unknown degree of error 
regarding how well the date of transmission is represented by the date of isolation. Finally the 
presence of SNPs in the primary case isolate of 26 pairs (averaging 0.64 SNPs per pair) that 
were not found in the secondary suggests that the sampled isolate is unlikely to represent the 
transmitted population. 
Figure 3 Poor correlation between time and number of SNPs accumulated in the 
secondary case isolate for drug resistant and sensitive isolates. Three pairs were excluded 
(see main text). SNPs conferring drug resistance were also removed. Resistant isolates are 
classed as isolates phenotypically resistant to atleast isoniazid, streptomycin, ethambutol or 
rifampicin. 
To control for the sources of error described above, the mutation rate was also inferred from 
the entire dataset, thus not requiring assumptions about the routes of transmission. A date of 
isolation was available for 197 of the isolates. The presence of a clock-like signal in this 
dataset was investigated using Path-O-Gen [21], which roots the maximum-likelihood tree at 
the position that is most compatible with the assumption of the presence of a molecular clock. 
Lineage specific phenotypes have been frequently proposed [33,34], and due to the 
possibility that the different lineages may have different mutation rates we carried out this 
analysis per lineage. An absence of correlation between the accumulation of SNPs and time 
was observed for all the lineages (Figure 4). In order to control for any time dependent 
variations in substitution rate and cluster specific phenotypes, we also carried out this 
analysis on five of the largest clusters which are more likely to represent the raw 
accumulation of SNPs in the absence of selection (Figure 5a). The linear regression slope 
ranged from 0.08 to 0.43 SNPs per genome per year, with this variation probably reflecting 
the small number of isolates and SNPs observed. When the cluster data was combined, a 
mean rate could be estimated at 0.27 SNPs per genome per year (95% CI 0.13, 0.41) (Figure 
5b). Additionally, when we plotted the age of the clusters against the number of SNPs 
accumulated, controlling for the number of isolates, we also calculated a similar rate of 0.34 
SNPs per genome per year (Additional file 6). 
Figure 4 Per lineage root to tip plot. Lineages were rooted using their topology in the entire 
maximum likelihood tree, and the number of SNPs accumulated from the root was plotted 
against date of isolation. Correlation is poor for all lineages, with r squared values of 
0.002,0.03,0.006 and 0.06 for Euro American, East African. 
Figure 5 Date of collection vs. root to tip SNP distance of the 5 largest clusters. A. 
Clusters were rooted using their topology in the entire maximum likelihood tree. Linear 
regression was fitted using Path-O-Gen [21]. B. Data combined from A. Time represents days 
since first isolation in the cluster. Shaded area indicates 95% confidence interval. 
In summary, three methods agreed on an average rate of ~0.3 SNPs per genome per year 
which is remarkably similar to that estimated by Ford et al. [10] using the tuberculosis 
macaque infection model. However, the correlation co-efficient was consistently poor 
(maximum r2 value of 0.6 in one case) and the level of variation observed at the isolate level 
was high. This is likely due to the very low rate and stochastic nature of SNP accumulation, 
and indicates that this estimate needs to be used with caution. 
Using the structure of the phylogeny to exclude transmission 
Instead of looking at possible transmission events in isolation, deep sampling of a 
phylogenetic cluster can provide a context, which can be used to make more confident 
inferences. The structure of a phylogeny can be used to assess whether a direct transmission 
event is likely to have occurred. Isolates that represent a recent transmission event are 
expected to be adjacent on the tree and share a most recent common ancestor, as shown in 
Figure 6d. If other isolates occupy the common nodes between the linked isolates in question, 
then this is evidence against direct transmission. This situation was identified for two of the 
pairs in the study (Figure 6a and 6b) which differed by 5 and 8 SNPs respectively. However, 
it is possible that the source case could have been carrying an infection with a “cloud” of 
diversity as observed previously [35]. In such a scenario, the entire cluster may in fact 
represent within patient diversity and each patient isolate is effectively a sample of this. As 
liquid cultures (i.e. not colony purified) were used in this study we were able to look for 
evidence of this by inspecting whether heterozygosity was identifiable in the variable 
positions between the pairs. We found no such evidence, and in the absence of multiple 
samples from each patient, this strongly suggests that these pairs do not represent direct 
transmission events. 
Figure 6 Exclusion of epidemiologically linked pairs based on phylogenetic position. Red 
indicates primary case isolate, blue is the secondary case isolate. A: excluded pair 1. B: 
excluded pair 2. C: Excluded pair with SNP difference of 149. N09501026 shares a deletion 
with an isolate in a different study [36]. D: Example of expected phylogenetic positioning of 
direct transmission pairs, brackets indicate paired isolates. 
One pair from the East Asian linage had a particularly large SNP difference of 149 (Figure 
6c). The suspected source case patient lived in the same street as the suspected secondary 
case patient. It is however unclear if they were in direct contact with each other. Both isolates 
shared an IS6110 RLFP pattern but their 24-locus VNTR pattern differed in 6 loci. With no 
detectable evidence of recombination or SNPs in possible hypermutator genes, we examined 
the sequencing data more closely and we were able to detect two independent deletions in the 
strains. The large deletion of part of the pks1 gene found in the source isolate was found in 
another East Asian strain, Beijing 30, in a previous study [36]. This suggests that these non-
epidemiologically linked isolates share a more recent common ancestor than the ancestor of 
epidemiologically linked pair. This evidence along with the large SNP difference means we 
can be confident in excluding the possibility of recent direct transmission. In the absence of 
whole genome sequencing, the clear genetic separation of these isolates would have been un-
detected. 
Identifying novel transmission events 
In low incidence countries, isolates of the same RFLP type isolated from different patients 
may be indicative of patient-patient transmission. In this dataset, 572 pairs of isolates had 
identical RFLP types, which had SNP distances ranging from 0–149, with a median of two 
SNPs. Figure 7b, further confirms that the linked pair with a SNP distance of 149 is a clear 
outlier showing that it is distinct from the rest same-RFLP and epidemiologically linked 
pairs. 95% of same-RFLP pairs have SNP distances under 11, indicating that in general RFLP 
type is a good indicator of phylogenetic relatedness. However, whole genome sequencing 
provides a much higher resolution. For example in Figure 6d, all of the isolates in this cluster 
would be indistinguishable via RFLP, but at the whole genome level individual transmission 
events can be inferred. Figure 7b demonstrates that many pairs of isolates of the same RFLP 
type, with currently no known epidemiological link, have SNP distances which overlap with 
the range observed between the 94 linked pairs. 
Figure 7 Pairwise SNP differences between isolates. A: Pairwise SNP difference between 
all 199 isolates, the peaks represent the pairwise differences between the major lineages. Box 
indicates subsection shown in B: pairwise SNP differences under 150 SNPs for linked and 
unlinked pairs. There are many unlinked pairs that have SNP distances which overlap with 
the distribution of SNP distances for linked pairs. 
Strikingly 82 pairs of these non-linked isolates, of the sample RFLP type, had a SNP 
difference of zero. This suggests that amongst these pairs there may be previously un-
detected transmission events. The range of date intervals between these pairs ranged from 
zero days to almost 5 years, which further demonstrates the low and variable mutation rate. In 
the absence of epidemiological evidence, and the low and variable mutation rate observed, 
we cannot confidently assess whether direct transmission has occurred in these cases, 
however this information would provide valuable evidence in a clinical setting, informing 
further investigation and contact tracing. 
Discussion 
In summary, the low mutation rate of M. tuberculosis means that even at the highest 
resolution provided by whole genome sequencing it is still difficult to confidently affirm the 
inferences of transmission made by traditional epidemiological techniques. This means it is 
very difficult to determine transmission inclusively. However, whole genome sequencing 
does in some cases allow us to exclude direct transmission, by using the phylogenetic context 
provided by other strains. Not only does whole genome sequencing provide the inter-cluster 
differentiation provided by current typing methods, but it also achieves intra-cluster 
resolution which can be used to inform epidemiological investigation. 
At the cluster level we were able to estimate an average mutation rate of 0.3 SNPs per 
genome per year, which is remarkably close to estimates made by Ford et al. [10]. This 
confirms the extremely low rate of accumulation of variation that characterizes M. 
tuberculosis, which is approximately 3 times and 44 times slower than that observed in 
Escherichia coli and Staphylococcus aureus, respectively [37]. It is possible that lack of 
coverage and mapping to repetitive regions and members of PE and PPE gene families may 
have resulted in a lower estimated mutation rate. However, it is worth noting that only 5% of 
the genome on average was unrepresented in this analysis so any effects on the estimated 
mutation rate are likely to be negligible. 
We were unable to detect a clock-like signal at a larger phylogenetic scale (at the lineage 
level), probably reflecting the different processes of fixation and substitution having variable 
influences on different parts of the evolutionary history. However, at the intra-cluster level 
and between the epidemiologically linked pairs, we observed a large level of variation around 
the mean, which is in contrast to observations of some other bacteria [38,39]. There are a 
variety of factors that may have contributed to this variability. Latency is common in 
tuberculosis infection and could result in considerable discrepancies in the apparent rate of 
mutation over time. However, Ford et al. recently showed that the mutation rate during 
latency in macaques was similar to that during active infection [10]. Within host selection for 
factors such as drug resistance may also result in variation in the accumulation of SNPs over 
time, as observed for a single patient [9]. However, we propose that the most important factor 
is probably the low mutation rate itself, meaning over short time scales only a weak signal of 
a molecular clock can be detected. 
This variability means that although a molecular clock may be detectable over longer time 
frames, it is only an aggregate measure and should be used with extreme caution when 
applying it to infer local transmission or date recent evolutionary events. Furthermore, while 
mutation rate can be used to strengthen or exclude epidemiological links, it cannot be used 
alone to infer direct transmission, particularly due its slow rate. We found no evidence of 
hyper-mutation in our dataset, and this has not been reported in clinical M. tuberculosis 
isolates to our knowledge. However it is possible that treatment may impose selection 
pressures on isolates that could affect the observed rate of fixation, and this should be 
considered. 
In a recent investigation of tuberculosis transmission chains in the UK [11], an estimate of 
0.5 SNPs per genome per year was derived using whole genome sequences from both within-
patient and within-household longitudinal sampling. This estimate was based on the number 
of SNPs accumulated between the first and last sequenced isolate from each patient or 
transmission chain. Interestingly, the estimate for within-patient mutation rate was identical 
to our estimate of 0.3 SNPs per genome per year. The higher between-patient rate they 
estimated may reflect the multiple sources of error when using the inferred epidemiological 
links to derive mutation rates, which we observed in our dataset. They used this estimate to 
set a cut-off of ≤5 SNPs for cases less than three years apart. Our more in-depth analysis of 
the molecular clock reveals a high level of variation which suggests that using a simple cut-
off may not be entirely accurate for confirming transmission, but that the phylogenetic 
context provided by deep sampling of clusters may be more informative. 
Conclusions 
This dataset reveals that over transmission time scales, the molecular clock of M. tuberculosis 
is both slow and variable, indicating that genetic distance alone cannot be used to confidently 
infer transmission. However we propose future transmission studies of M. tuberculosis will 
benefit from whole genome sequencing through the increased resolution it provides. In 
addition we demonstrate that deep sampling of a phylogenetic cluster will provide the context 
to allow exclusion of possible transmission events. The establishment of whole-genome 
databases will further enhance the possibility to compare samples to exclude or propose 
transmission. 
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